1
|
Vallin M, Tomson G, Kampmann B, Engebretsen E, Swartling Peterson S, Wanyenze RK, Ottersen OP. Life Science 2.0: reframing the life science sector for 'the benefit on mankind'. Glob Health Action 2024; 17:2330758. [PMID: 38577884 PMCID: PMC11000595 DOI: 10.1080/16549716.2024.2330758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2024] [Accepted: 03/11/2024] [Indexed: 04/06/2024] Open
Abstract
The COVID-19 pandemic put the life science sector to the test. Vaccines were developed at unprecedented speed, benefiting from decades of fundamental research and now honoured by a Nobel Prize. However, we saw that the fruits of science were inequitably distributed. Most low- and middle-income countries were left behind, deepening the inequalities that the Sustainable Development Goals were set to reduce. We argue that the life science sector must reinvent itself to be better and more equitably prepared for the next health crisis and to ensure fair access to health across current and future generations. Our recommendations include global governance, national strategies and the role of universities and corporations. Improved and more equitable health care should be centre stage for global health action and a core mission of a reframed Life Science sector - what we call Life Science 2.0.Paper ContextMain findings: During the COVID-19 pandemic the Life Science sector stepped up to the challenge, but vaccines and medicines were not equitably distributed.Added knowledge: Obstacles were identified that hindered global access to medical innovations.Global health impact for policy and action: Global and national governance, universities and the private sector should join forces to create a Life Science sector (Life Science 2.0) that affords equitable access to medical advances across geographical and generational boundaries and socio-economic strata.
Collapse
Affiliation(s)
- Michaela Vallin
- Chemical Biology Consortium Sweden, SciLifeLab, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
| | - Göran Tomson
- Department of Learning, Informatics, Management, and Ethics, Karolinska Institutet, Stockholm, Sweden
| | - Beate Kampmann
- Charité Centre of Global Health, Charité Universitätsmedizin, Berlin, Germany
| | | | - Stefan Swartling Peterson
- Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden
- College of Health Sciences, School of Public Health, Makerere University, Kampala, Uganda
| | - Rhoda K. Wanyenze
- College of Health Sciences, School of Public Health, Makerere University, Kampala, Uganda
| | - Ole Petter Ottersen
- Charité Centre of Global Health, Charité Universitätsmedizin, Berlin, Germany
- Sustainable Health Unit and Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
- Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
| |
Collapse
|
2
|
Sahoo D, Karnesh SJ, Abhishekh B. Effect of Vaccination on Seroprevalence of COVID-19 among Blood donors - A cross-sectional Analytic Study from South India. Indian J Hematol Blood Transfus 2024; 40:443-447. [PMID: 39011267 PMCID: PMC11246388 DOI: 10.1007/s12288-023-01716-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2023] [Accepted: 11/16/2023] [Indexed: 07/17/2024] Open
Abstract
India achieved impressive strides by providing 1.7 billion doses of the COVID-19 vaccine to more than 940 million people, attaining 100% first dose coverage and 80% overall immunization coverage as of February 9, 2022. Compared to unvaccinated individuals, vaccinated people have considerably decreased risks of infection, serious illness, hospitalization, and death. With the help of this study, we determined the prevalence of COVID-19 IgG antibodies with respect to vaccination. The cross-sectional analytical study was conducted from July 2021 to April 2022 on 809 healthy donors. All donor samples were screened for COVID-19 IgG antibodies against S1 protein using IgG ELISA kits (Qualisa COVID-19 IgG kits, Tulip, Goa, India). Data regarding COVID-19 infection history, vaccination status, type of vaccine, and the number of doses were obtained. All data were entered in Microsoft Excel and analyzed using SPSS version 21. Out of 809 blood donors, a total of 650 participants were vaccinated, among which 89.5% had COVID-19 IgG antibodies and 10.5% had no antibodies. Out of the 159 who had not taken vaccination, 52.8% of the participants had COVID-19 IgG antibodies, and 47.2% of the donors had no COVID-19 IgG antibodies. A total of 617 participants have taken the Covishield vaccine, of which 90.2% had COVID-19 IgG antibodies. A total of 32 donors have taken Covaxin, of which 78.1% had COVID-19 IgG antibodies. The above study has shown that COVID-19 vaccination enhances covid antibody formation, and multiple doses of vaccine ensure longevity of these antibodies.
Collapse
Affiliation(s)
- Dibyajyoti Sahoo
- Department of Transfusion Medicine, JIPMER (Jawaharlal Institute of Postgraduate Medical Education and Research), Puducherry, India
| | - Sunil Jai Karnesh
- Department of Transfusion Medicine, JIPMER (Jawaharlal Institute of Postgraduate Medical Education and Research), Puducherry, India
| | - B. Abhishekh
- Department of Transfusion Medicine, JIPMER (Jawaharlal Institute of Postgraduate Medical Education and Research), Puducherry, India
| |
Collapse
|
3
|
Shen Z, Li Q, Wu J, Zhu D, Bai J, Ren R, Zhang J, Li Y, Wang M, Gu J, Li Y, Dong W, Wang H, Sun T, Yang F, Zhou X, Yang J, Tarimo CS, Ma M, Feng Y, Miao Y. Dynamic evolution of COVID-19 vaccine hesitancy over 2021-2023 among Chinese population: Repeated nationwide cross-sectional study. J Med Virol 2024; 96:e29800. [PMID: 39014958 DOI: 10.1002/jmv.29800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2024] [Revised: 06/29/2024] [Accepted: 07/04/2024] [Indexed: 07/18/2024]
Abstract
Globally, the rollout of COVID-19 vaccine had been faced with a significant barrier in the form of vaccine hesitancy. This study adopts a multi-stage perspective to explore the prevalence and determinants of COVID-19 vaccine hesitancy, focusing on their dynamic evolutionary features. Guided by the integrated framework of the 3Cs model (complacency, confidence, and convenience) and the EAH model (environmental, agent, and host), this study conducted three repeated national cross-sectional surveys. These surveys carried out from July 2021 to February 2023 across mainland China, targeted individuals aged 18 and older. They were strategically timed to coincide with three critical vaccination phases: universal coverage (stage 1), partial coverage (stage 2), and key population coverage (stage 3). From 2021 to 2023, the surveys examined sample sizes of 29 925, 6659, and 5407, respectively. The COVID-19 vaccine hesitation rates increased from 8.39% in 2021 to 29.72% in 2023. Urban residency, chronic condition, and low trust in vaccine developer contributed to significant COVID-19 vaccine hesitancy across the pandemic. Negative correlations between the intensity of vaccination policies and vaccine hesitancy, and positive correlations between vaccine hesitancy and long COVID, were confirmed. This study provides insights for designing future effective vaccination programs for emerging vaccine-preventable infectious X diseases.
Collapse
Affiliation(s)
- Zhanlei Shen
- Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China
- Henan Province Engineering Research Center of Health Economy & Health Technology Assessment, Zhengzhou, China
| | - Quanman Li
- Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China
- Henan Province Engineering Research Center of Health Economy & Health Technology Assessment, Zhengzhou, China
| | - Jian Wu
- Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China
- Henan Province Engineering Research Center of Health Economy & Health Technology Assessment, Zhengzhou, China
| | - Dongfang Zhu
- Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China
- Henan Province Engineering Research Center of Health Economy & Health Technology Assessment, Zhengzhou, China
| | - Junwen Bai
- Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China
- Henan Province Engineering Research Center of Health Economy & Health Technology Assessment, Zhengzhou, China
| | - Ruizhe Ren
- Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China
- Henan Province Engineering Research Center of Health Economy & Health Technology Assessment, Zhengzhou, China
| | - Jingbao Zhang
- Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China
- Henan Province Engineering Research Center of Health Economy & Health Technology Assessment, Zhengzhou, China
| | - Yi Li
- Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China
- Henan Province Engineering Research Center of Health Economy & Health Technology Assessment, Zhengzhou, China
| | - Meiyun Wang
- Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan, China
| | - Jianqin Gu
- School of Medicine, Southern University of Science and Technology, Guangdong, China
| | - Yinfei Li
- Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan, China
| | - Wenyong Dong
- Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan, China
| | - Haipeng Wang
- Center for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Tao Sun
- Department of Health Policy and Management, School of Public Health, Hangzhou Normal University, Hangzhou, China
| | - Fan Yang
- School of Public Health, Fudan University, NHC Key Lab of Health Technology Assessment, Fudan University, Shanghai, China
| | - Xue Zhou
- College of Health Management, Mudanjiang Medical University, Mudanjiang, Heilongjiang, China
| | - Jian Yang
- Department of Global Health, School of Public Health, Peking University, Beijing, China
| | - Clifford Silver Tarimo
- Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China
- Henan Province Engineering Research Center of Health Economy & Health Technology Assessment, Zhengzhou, China
| | - Mingze Ma
- Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China
- Henan Province Engineering Research Center of Health Economy & Health Technology Assessment, Zhengzhou, China
| | - Yifei Feng
- Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China
- Henan Province Engineering Research Center of Health Economy & Health Technology Assessment, Zhengzhou, China
| | - Yudong Miao
- Department of Health Management, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China
- Henan Province Engineering Research Center of Health Economy & Health Technology Assessment, Zhengzhou, China
| |
Collapse
|
4
|
Ferris BF, Balasubramanian S, Rajamanickam A, Munisankar S, Dasan B, Menon PA, Loke P, Babu S, Chami GF. Relative contribution of biomedical, demographic, and socioeconomic factors to COVID-19 vaccine receipt in rural India. PLoS One 2024; 19:e0305819. [PMID: 38913614 PMCID: PMC11195973 DOI: 10.1371/journal.pone.0305819] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Accepted: 06/05/2024] [Indexed: 06/26/2024] Open
Abstract
BACKGROUND In the first year of roll-out, vaccination for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) prevented almost 20 million deaths from coronavirus disease 2019 (COVID-19). Yet, little is known about the factors influencing access to vaccination at the individual level within rural poor settings of low-income countries. The aim of this study was to examine determinants of vaccine receipt in rural India. METHODS A census of a rural village in Tamil Nadu was undertaken from June 2021 to September 2022. We surveyed 775 participants from 262 households. Household-level data on socioeconomic status (SES), water, sanitation, and hygiene practices, and individual-level demographic information, travel history, and biomedical data, including anthropometry, vital signs, and comorbidities, were collected. Logistic regression models with 5-fold cross-validation were used to identify the biomedical, demographic, and socioeconomic determinants of vaccine receipt and the timing of receipt within the first 30 days of eligibility. Vaccine ineligible participants were excluded leaving 659 eligible participants. There were 650 eligible participants with complete biomedical, demographic, and socioeconomic data. RESULTS There were 68.0% and 34.0% of individuals (N = 650) who had received one and two vaccine doses, respectively. Participants with household ownership of a permanent account number (PAN) or ration card were 2.15 (95% CI:1.32-3.52) or 3.02 (95% CI:1.72-5.29) times more likely to receive at least one vaccine dose compared to households with no ownership of such cards. Participants employed as housewives or self-employed non-agricultural workers were 65% (95% CI:0.19-0.67) or 59% (95% CI:0.22-0.76) less likely to receive at least one vaccine dose compared to salaried workers. Household PAN card ownership, occupation and age were linked to the timing of vaccine receipt. Participants aged ≤18 and 45-60 years were 17.74 (95% CI:5.07-62.03) and 5.51 (95% CI:2.74-11.10) times more likely to receive a vaccine within 30 days of eligibility compared to 19-44-year-olds. Biomedical factors including BMI, vital signs, comorbidities, and COVID-19 specific symptoms were not consistently associated with vaccine receipt or timing of receipt. No support was found that travel history, contact with COVID-19 cases, and hospital admissions influenced vaccine receipt or timing of receipt. CONCLUSION Factors linked to SES were linked to vaccine receipt, more so than biomedical factors which were targeted by vaccine policies. Future research should explore if government interventions including vaccine mandates, barriers to vaccine access, or peer influence linked to workplace or targeted vaccine promotion campaigns underpin these findings.
Collapse
Affiliation(s)
- Bethany F. Ferris
- Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, Oxfordshire, United Kingdom
| | - Suganthi Balasubramanian
- National Institutes of Health – National Institute for Research in Tuberculosis -International Center for Excellence in Research (NIH-ICER), Chennai, Tamil Nadu, India
| | - Anuradha Rajamanickam
- National Institutes of Health – National Institute for Research in Tuberculosis -International Center for Excellence in Research (NIH-ICER), Chennai, Tamil Nadu, India
| | - Saravanan Munisankar
- National Institutes of Health – National Institute for Research in Tuberculosis -International Center for Excellence in Research (NIH-ICER), Chennai, Tamil Nadu, India
| | - Bindu Dasan
- National Institutes of Health – National Institute for Research in Tuberculosis -International Center for Excellence in Research (NIH-ICER), Chennai, Tamil Nadu, India
| | - Pradeep A. Menon
- Indian Council of Medical Research – National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India
| | - P'ng Loke
- Laboratory of Parasitic Diseases, National Institutes of Health National Institutes of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States of America
| | - Subash Babu
- National Institutes of Health – National Institute for Research in Tuberculosis -International Center for Excellence in Research (NIH-ICER), Chennai, Tamil Nadu, India
- Laboratory of Parasitic Diseases, National Institutes of Health National Institutes of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States of America
| | - Goylette F. Chami
- Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, Oxfordshire, United Kingdom
| |
Collapse
|
5
|
Low JM, Afroze S, Al Mamun MA, Afroze S, Tisha S, Hossain MA, Mannan MA, Dey SK, Amin Z, Shahidullah M. Short term Outcomes of COVID-19 Vaccines Among Lactating Mother and Child Dyads in Bangladesh: A Multi-centre, Cross-sectional Study. Matern Child Health J 2024; 28:1080-1085. [PMID: 38252330 DOI: 10.1007/s10995-023-03881-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/20/2023] [Indexed: 01/23/2024]
Abstract
INTRODUCTION The aims of the study are to: (1) determine the short-term reactogenicity of WHO-approved COVID-19 vaccines (i.e., Pfizer-BioNTech, Moderna, Sinovac, Oxford-AstraZeneca, Johnson and Johnson, Covaxin) amongst lactating women and their children, and 2) evaluate lactation-related outcomes following the same vaccines in Bangladesh. METHODS This was a multi-centre, self-reported, cross-sectional study of lactating woman-child dyads in Bangladesh. Demographics, past medical history, breastfeeding history and clinical outcomes of lactating woman-child dyads at least 7 days after the last dose of vaccine were determined through a structured questionnaire. RESULTS There were 750 participants from four centres. The mean age of lactating women and children surveyed were 27.6 (SD ± 4.6) years and 10.3 (SD ± 6.7) months, respectively. Majority (81.2%; 608 of 750) received 2 doses of COVID-19 vaccinations while lactating. Almost all (99.9%; 749 of 750) vaccinated lactating women surveyed reported no change in human milk supply. More than half of the participants (56.9%; 373 of 656) reported no symptoms after both doses of COVID-19 vaccines. There were no serious adverse events such as anaphylaxis or hospital admission. Majority of the lactating women (98.9%; 742 of 750) reported that the children whom they breastfed had no symptoms such as fever or cough. DISCUSSION This large study of lactating woman-child dyads in Bangladesh, who received a diverse range of WHO-approved COVID-19 vaccines, showed no serious short-term adverse effects.
Collapse
Affiliation(s)
- Jia Ming Low
- Department of Neonatology, Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, Singapore, Singapore
- Department of Paediatrics, Yong Loo Lin School of Singapore, National University of Singapore, Singapore, Singapore
| | - Sharmin Afroze
- Department of Neonatology, Dr. M R Khan Shishu Hospital and Institute of Child Health, Mirpur, Dhaka, Bangladesh
| | - Mohammod Abdullah Al Mamun
- Department of Paediatric Cardiology, Bangladesh Shishu (Children) Hospital and Institute, Sher- E-Bangla Nagar, Dhaka, Bangladesh
| | - Sadia Afroze
- The Second Urban Primary Health Care Project (UPHCSDP-II), DSCC, PA-2, BAPSA, Dhaka, Bangladesh
| | | | - Md Arif Hossain
- Department of Neonatology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh
| | - Md Abdul Mannan
- Department of Neonatology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh
| | - Sanjoy Kumer Dey
- Department of Neonatology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh
| | - Zubair Amin
- Department of Neonatology, Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, Singapore, Singapore.
- Department of Paediatrics, Yong Loo Lin School of Singapore, National University of Singapore, Singapore, Singapore.
| | - Mohammod Shahidullah
- Department of Neonatology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh
| |
Collapse
|
6
|
Verma VK, Yadav R, Beevi SS, Mohod AS, Mancharla S, Damodar N, Darapuneni RC, Reddy SG, Upendram P, Salt MN, Kulkarni P, Sahu S, Bollineni BR. Differential host responses to COVID-19: Unraveling the complexity. Diagn Microbiol Infect Dis 2024; 109:116281. [PMID: 38537507 DOI: 10.1016/j.diagmicrobio.2024.116281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2023] [Revised: 03/20/2024] [Accepted: 03/21/2024] [Indexed: 04/30/2024]
Abstract
These diverse outcomes of Covid-19 are influenced by various factors including age, gender, underlying health conditions, immune responses, viral variants, external factors, and overall quality of life. Demographic analysis of patients aged 0-18 years experienced mild to moderate cases, above 55 years with co-morbidities, were more severely affected.COVID-19 incidence was higher in males (58 %) & (42 %) in females. The reduced expression of Toll-like receptors (TLR) in severe and critical patients is a crucial determinant. This reduced TLR expression is primarily attributed to the dominance of the PLpro viral protein of COVID-19. Disease enrichment analysis highlights the long-term impact of COVID-19, which can lead to post-recovery complications such as hypertension, diabetes, cardiac diseases, and brain ischemia in Covid-19 patients. In conclusion, a comprehensive strategy targeting key factors like PLpro, TLR, and inflammatory cytokines such as IL-1 and IL-6 could offer an effective approach to mitigate the devastating effects of COVID-19.
Collapse
Affiliation(s)
- Vinod Kumar Verma
- KIMS Foundation and Research Centre, KIMS Hospital, Minister Road, Secunderabad, Telangana, India.
| | - Rahul Yadav
- KIMS Foundation and Research Centre, KIMS Hospital, Minister Road, Secunderabad, Telangana, India
| | - Syed Sultan Beevi
- KIMS Foundation and Research Centre, KIMS Hospital, Minister Road, Secunderabad, Telangana, India.
| | - Annie S Mohod
- KIMS Foundation and Research Centre, KIMS Hospital, Minister Road, Secunderabad, Telangana, India
| | - Shravya Mancharla
- KIMS Foundation and Research Centre, KIMS Hospital, Minister Road, Secunderabad, Telangana, India
| | - Neha Damodar
- KIMS Foundation and Research Centre, KIMS Hospital, Minister Road, Secunderabad, Telangana, India
| | | | - Sukurtha Gopal Reddy
- Diagnostics Division, Krishna Institute of Medical Sciences, Minister Road, Secunderabad, Telangana, India
| | - Pavani Upendram
- Department of Genetics, Krishna Institute of Medical Sciences, Minister Road, Secunderabad, Telangana, India
| | - Mohammad Nawaz Salt
- Department of Pulmonology, Krishna Institute of Medical Sciences, Minister Road, Secunderabad, Telangana, India
| | - Praveen Kulkarni
- Department of Internal Medicine, Krishna Institute of Medical Sciences, Minister Road, Secunderabad, Telangana, India
| | - Sambit Sahu
- Department of Critical care, Krishna Institute of Medical Sciences, Minister Road, Secunderabad, Telangana, India
| | - Bhaskar Rao Bollineni
- KIMS Foundation and Research Centre, KIMS Hospital, Minister Road, Secunderabad, Telangana, India
| |
Collapse
|
7
|
Saeed S, Niazi F, Kaur KN, Rana S, Singhal M, Singh H. Assessing patient satisfaction among COVID-19 survivors in Northeast India: a cross-sectional study. Front Med (Lausanne) 2024; 11:1308288. [PMID: 38873210 PMCID: PMC11172152 DOI: 10.3389/fmed.2024.1308288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2023] [Accepted: 05/21/2024] [Indexed: 06/15/2024] Open
Abstract
Introduction This study investigates patient satisfaction among COVID-19 survivors in Northeast India, motivated by the unique long-term healthcare needs of survivors and the critical role of patient satisfaction in assessing and enhancing healthcare quality. By focusing on this underexplored region, the research aims to uncover insights that can guide improvements in patient-centered care and healthcare service delivery in similar contexts. Materials and methods The study was conducted using a Simple Random Sampling technique. Data were collected through telephone interviews using a semi-structured questionnaire, including the Patient Satisfaction Questionnaire-18 (PSQ-18) for analysis. The PSQ-18 yielded seven subscale scores representing different dimensions of patient satisfaction. Statistical analysis using SPSS software was conducted to summarize socio-demographic characteristics, medical history, and patient satisfaction levels, employing both descriptive and inferential statistics. Result The results indicated a high acceptance of COVID-19 vaccination, with the majority of participants having received both doses. Patient satisfaction with healthcare services is generally positive, particularly in aspects related to doctor-patient communication and medical care quality. However, there are notable concerns regarding the affordability and timeliness of care. Regional variations across states, as well as factors like education and income, significantly influence patient satisfaction levels. Conclusion The study revealed generally good patient satisfaction levels in Northeast India. However, challenges in healthcare affordability and timeliness persist, influenced by regional disparities and socio-economic factors. Targeted interventions are needed to improve healthcare in the region.
Collapse
Affiliation(s)
- Shazina Saeed
- Amity Institute of Public Health and Hospital Administration, Amity University, Noida, India
- Faculty of Pharmacy, School of Pharmaceutical and Population Health Informatics, DIT University, Dehradun, India
| | - Farah Niazi
- Laboratory of Disease Dynamics & Molecular Epidemiology, Amity Institute of Public Health and Hospital Administration, Amity University, Noida, India
| | - Karuna Nidhi Kaur
- Laboratory of Disease Dynamics & Molecular Epidemiology, Amity Institute of Public Health and Hospital Administration, Amity University, Noida, India
| | - Shweta Rana
- Division of Biomedical Informatics (BMI), Indian Council of Medical Research, New Delhi, India
| | - Manmohan Singhal
- Faculty of Pharmacy, School of Pharmaceutical and Population Health Informatics, DIT University, Dehradun, India
| | - Harpreet Singh
- Division of Biomedical Informatics (BMI), Indian Council of Medical Research, New Delhi, India
| |
Collapse
|
8
|
Aggarwal S, Singh L, Alam U, Sharma S, Saroj SK, Zaman K, Usman M, Kant R, Chaturvedi HK. COVID-19 vaccine hesitancy among adults in India: A primary study based on health behavior theories and 5C psychological antecedents model. PLoS One 2024; 19:e0294480. [PMID: 38722922 PMCID: PMC11081298 DOI: 10.1371/journal.pone.0294480] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2023] [Accepted: 11/02/2023] [Indexed: 05/13/2024] Open
Abstract
Despite the significant success of India's COVID-19 vaccination program, a sizeable proportion of the adult population remains unvaccinated or has received a single dose of the vaccine. Despite the recommendations of the Government of India for the two doses of the COVID-19 vaccine and the precautionary booster dose, many people were still hesitant towards the COVID-19 full vaccination. Hence, this study aimed to identify the primary behavioral and psychological factors contributing to vaccine hesitancy. Cross-sectional data was collected via a multi-stage sampling design by using a scheduled sample survey in the Gorakhpur district of Uttar Pradesh, India, between 15 July 2022 to 30 September 2022. This study has utilized three health behavior models-the Health Belief Model (HBM), the Theory of Planned Behavior (TPB), and the 5C Psychological Antecedents of vaccination, and employed bivariate and multivariable binary logistic regression model to assess the level of vaccine hesitancy and predictive health behavior of the respondents. Results indicate that among the constructs of the HBM and 5C Antecedents models, "perceived benefits", "confidence" and "collective responsibility" showed a lesser likelihood of COVID-19 vaccine hesitancy. However, in the TPB model constructs, a 'negative attitude towards the vaccine' showed a four times higher likelihood of COVID-19 vaccine hesitancy. From the future policy perspective, this study suggested that addressing the issue of 'negative attitudes towards the vaccine' and increasing the trust or confidence for the vaccine through increasing awareness about the benefits of the vaccination in India may reduce vaccine hesitancy.
Collapse
Affiliation(s)
- Sumit Aggarwal
- Indian Council of Medical Research- Headquarters (ICMR-Hqrs), Ansari Nagar, New Delhi, India
| | - Lucky Singh
- ICMR- National Institute of Medical Statistics (ICMR-NIMS), Ansari Nagar, New Delhi, India
| | - Umaer Alam
- ICMR-Regional Medical Research Centre (RMRC), Gorakhpur, Uttar Pradesh, India
| | - Saurabh Sharma
- ICMR- National Institute of Medical Statistics (ICMR-NIMS), Ansari Nagar, New Delhi, India
| | - Shashi Kala Saroj
- ICMR- National Institute of Medical Statistics (ICMR-NIMS), Ansari Nagar, New Delhi, India
| | - Kamran Zaman
- ICMR-Regional Medical Research Centre (RMRC), Gorakhpur, Uttar Pradesh, India
- ICMR-National Institute of Traditional Medicine (ICMR-NITM), Belagavi Karnataka, India
| | - Mohd Usman
- ICMR- National Institute of Medical Statistics (ICMR-NIMS), Ansari Nagar, New Delhi, India
| | - Rajni Kant
- ICMR-Regional Medical Research Centre (RMRC), Gorakhpur, Uttar Pradesh, India
| | | |
Collapse
|
9
|
Mbonigaba E, Yu F, Reñosa MDC, Cho FN, Chen Q, Denkinger CM, A McMahon S, Chen S. Knowledge and trust of mothers regarding childhood vaccination in Rwanda. BMC Public Health 2024; 24:1067. [PMID: 38632541 PMCID: PMC11022416 DOI: 10.1186/s12889-024-18547-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2023] [Accepted: 04/08/2024] [Indexed: 04/19/2024] Open
Abstract
INTRODUCTION Knowledge and trust are some of the contributing factors to vaccine acceptance(VA) and Vaccine hesitancy (VH) is one of the top threats to global health. A significant drop in childhood vaccination has been observed in recent years. One important reason that influences mothers' choice to either postpone or avoid children's vaccinations is knowledge and trust in childhood vaccines. This study aimed to assess mothers' knowledge and trust on vaccination of their children, and to examine the association between vaccination knowledge and selected socio-demographic factors. METHODS A cross-sectional survey was conducted from January 2022 to March 2022 to assess the knowledge and trust of mothers regarding childhood vaccination. Data was collected with self-administered questionnaires. Multivariable logistic regression analysis was employed to assess factors associated with childhood vaccine knowledge and trust. RESULTS Of the 2,126 Rwandan parents who participated in the study, the proportions with good knowledge of - and good trust in childhood vaccination were 95.5% and 91.4%, respectively. The popular sources of information about childhood vaccination were health care professionals (91.8%) and mass media (28.9%). Multinomial logistic regression analysis showed that good knowledge of - and trust in childhood vaccination were associated with the relationship with child(ren), education, occupation, and monthly income. The Multinomial logistic regression also revealed that the determinants of good knowledge of - and trust in childhood vaccination were; caregiver (p = 4.0 × 10-4, adjusted Odds Ratio (aOR); 1.7, 95%C.I; 1.3 - 2.3), no formal educational status (p = 3.3 × 10-2, aOR; 1.7, 95%C.I; 1.0 - 3.0), the unemployed occupational status (p = 2.4 × 10-2, aOR; 1.2, 95%C.I; 1.0 - 1.4), and persons on more than $401 per month (p = 2.0 × 10-4, aOR; 3.5, 95%C.I; 1.8 - 6.8). CONCLUSION The majority of parents in Rwanda had both good knowledge of-and good trust regarding childhood vaccination. Public health strategies to promote vaccination, education programmes as well as improved communication tools between health care professionals/traditional leaders/religious leaders and parents need to be considered to achieve favourable vaccination attitudes and practices for all parents in Rwanda.
Collapse
Affiliation(s)
- Edward Mbonigaba
- Centre of Infectious Diseases, Division of Infectious Disease and Tropical Medicine, Universität Heidelberg, Heidelberg, Germany.
- College of Medicine and Health Sciences, School of Public, Health- University of Rwanda, Kigali, Rwanda.
| | - Fengyun Yu
- Interdisciplinary Centre for Scientific Computing, Universität Heidelberg, Heidelberg, Germany
| | - Mark Donald C Reñosa
- Heidelberg Institute of Global Health, Universität Heidelberg, Heidelberg, Germany
- Department of Epidemiology and Biostatistics, Research Institute for Tropical Medicine, Muntinlupa City, Philippines
| | - Frederick Nchang Cho
- , Buea, Cameroon
- Infectious Disease Laboratory, Faculty of Health Sciences, University of Buea, Buea, Cameroon
| | - Qiushi Chen
- Department of Industrial and Manufacturing Engineering, The Harold and Inge Marcus, The Pennsylvania State University, University ParkHarrisburg, PA, USA
| | - Claudia M Denkinger
- Centre of Infectious Diseases, Division of Infectious Disease and Tropical Medicine, Universität Heidelberg, Heidelberg, Germany
| | - Shannon A McMahon
- Centre of Infectious Diseases, Division of Infectious Disease and Tropical Medicine, Universität Heidelberg, Heidelberg, Germany
| | - Simiao Chen
- Centre of Infectious Diseases, Division of Infectious Disease and Tropical Medicine, Universität Heidelberg, Heidelberg, Germany
- Chinese Academy of Medical Sciences and Peking Union Medical College, Peking, China
| |
Collapse
|
10
|
Lei B, Mahajan A, Mallick B. Identifying and overcoming COVID-19 vaccination impediments using Bayesian data mining techniques. Sci Rep 2024; 14:8595. [PMID: 38615084 PMCID: PMC11016065 DOI: 10.1038/s41598-024-58902-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2023] [Accepted: 04/04/2024] [Indexed: 04/15/2024] Open
Abstract
The COVID-19 pandemic has profoundly reshaped human life. The development of COVID-19 vaccines has offered a semblance of normalcy. However, obstacles to vaccination have led to substantial loss of life and economic burdens. In this study, we analyze data from a prominent health insurance provider in the United States to uncover the underlying reasons behind the inability, refusal, or hesitancy to receive vaccinations. Our research proposes a methodology for pinpointing affected population groups and suggests strategies to mitigate vaccination barriers and hesitations. Furthermore, we estimate potential cost savings resulting from the implementation of these strategies. To achieve our objectives, we employed Bayesian data mining methods to streamline data dimensions and identify significant variables (features) influencing vaccination decisions. Comparative analysis reveals that the Bayesian method outperforms cutting-edge alternatives, demonstrating superior performance.
Collapse
Affiliation(s)
- Bowen Lei
- Department of Statistics, Texas A&M University, College Station, TX, USA
| | - Arvind Mahajan
- Department of Finance, Texas A&M University, College Station, TX, USA
| | - Bani Mallick
- Department of Statistics, Texas A&M University, College Station, TX, USA.
| |
Collapse
|
11
|
Balasubramaniam S, Bose P, Raviganesh PK, Pandian P, Selvaraj B, Sivaprakasam R, Balaji S, Am A, Sivakumar P, Ramasubramanian S. Vaccination and Its Impact on Lung Involvement in COVID-19 Patients: A Retrospective Study in India. Cureus 2024; 16:e58904. [PMID: 38800182 PMCID: PMC11117028 DOI: 10.7759/cureus.58904] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/24/2024] [Indexed: 05/29/2024] Open
Abstract
Background COVID-19, caused by SARS-CoV-2, led to a global pandemic necessitating urgent vaccine development and deployment. By the end of 2020, several vaccines had reached their clinical trial endpoints. India, leveraging its pharmaceutical prowess, developed two primary vaccines: CoviShield® and Covaxin®. Despite the availability of these vaccines, vaccine hesitancy became a notable challenge. This study aimed to assess the correlation between vaccination status and lung involvement in COVID-19 patients, aiming to fortify trust in vaccines and enhance vaccine uptake in India. Methods This retrospective cross-sectional study analyzed data from 272 patients treated at a designated COVID-19 Care Center in Chennai, India, from May to July 2021. Patients were divided into vaccinated and unvaccinated groups, with vaccinated individuals further categorized based on the type and dose of vaccine received (CoviShield® or Covaxin®). Lung involvement was assessed through CT chest scans, and statistical analyses were performed to compare the severity of lung involvement across different groups. Results The vaccinated group demonstrated significantly lower mean lung involvement (28%) compared to the unvaccinated group (34.8%). Within vaccinated individuals, no significant differences were observed between different vaccine types and doses, suggesting a generalized protective effect of COVID-19 vaccination against severe lung involvement. Conclusion Vaccination against COVID-19 significantly reduces the severity of lung involvement among patients, irrespective of the vaccine brand or dose. This study reinforces the importance of vaccination in mitigating the impact of COVID-19 and supports ongoing vaccination efforts.
Collapse
Affiliation(s)
| | - Priyadarsini Bose
- Internal Medicine, Government Medical College, Omandurar Government Estate, Chennai, IND
| | | | - Pravin Pandian
- Radiodiagnosis, Government Stanley Medical College and Hospital, Chennai, IND
| | - Balaji Selvaraj
- Radiodiagnosis, Government Medical College, Omandurar Government Estate, Chennai, IND
| | | | - Sangeetha Balaji
- Radiodiagnosis, Government Medical College, Omandurar Government Estate, Chennai, IND
| | - Abhilekshmi Am
- Radiodiagnosis, Government Medical College, Omandurar Government Estate, Chennai, IND
| | | | | |
Collapse
|
12
|
Thampy P, Sharma S, Joshi P, Raj MS, Rupani A, Tyagi S, Joshi A. COVID-19 Vaccine Hesitancy Among Healthcare Workers: A Phenomenological Study of Skepticism. Cureus 2024; 16:e58445. [PMID: 38765453 PMCID: PMC11099877 DOI: 10.7759/cureus.58445] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/17/2024] [Indexed: 05/22/2024] Open
Abstract
RATIONALE Despite the prioritizing the healthcare workers (HCWs) for COVID-19 in a systematized manner the phenomenon of vaccine hesitancy was observed in them. HCWs are presumed to be pre-emptive in up-taking the vaccine due to their closest association and having reasonable background information. Hence, we intended to explore and investigate the phenomenology of skepticism and hesitancy toward the COVID-19 vaccine among HCWs. METHOD A sequential explanatory mixed methods study design incorporating a baseline cross-sectional survey followed by qualitative and semiquantitative text-mining approach was adopted in a tertiary care center in Madhya Pradesh, India. Six hundred seventy-nine HCWs for quantitative data and 30 HCWs for qualitative interviews were surveyed. After determining the quantum and baseline traits of hesitant HCWs, 30 participants were purposively selected for in-depth qualitative analysis based on grounded theory using a framework approach and consolidated from the psychological and philosophical plane of skepticism. This was complemented by a semiquantitative text-mining approach using mono/bigram analysis and network plotting. RESULTS Approximately one-fifth of participants (18%,122 out of 679) were initially, and one-tenth of initially hesitant (10 out of 122) were terminally hesitant. Hesitant and non-hesitant participants were similar except for comorbidity status. Five themes emerged namely individual, vaccine-related, social, system, and contextual after thematic consolidation. Words/phrases indicating individualistic desire to knowing more, internal conflicts, and conjecture were mined further. The network plot showed diversified expressions of participants. CONCLUSION There seems to be a requirement to prime HCWs by offering objective information beforehand and removing diffidence using a systematic approach addressing the psychology and prevalent partisan belief in similar circumstances in the future.
Collapse
Affiliation(s)
- Parvathy Thampy
- Community and Family Medicine, All India Institute of Medical Sciences, Bhopal, Bhopal, IND
| | - Shweta Sharma
- Community Medicine, Lakshmi Narain Medical College and Research Centre, Bhopal, IND
| | - Pragya Joshi
- Department of Training & Placement, Oriental Institute of Science and Technology, Bhopal, IND
| | - Munna S Raj
- Internal Medicine, KIMSHEALTH, Thiruvananthapuram, IND
| | - Ashlesh Rupani
- Community Medicine, Government Medical College Jalgaon, Jalgaon, IND
| | - Shivank Tyagi
- Rajbhasha Department, All India Institute of Medical Sciences, Bhopal, Bhopal, IND
| | - Ankur Joshi
- Community and Family Medicine, All India Institute of Medical Sciences, Bhopal, Bhopal, IND
| |
Collapse
|
13
|
Ganju P, Kalaiyarasi JP, Karunakaran P, Veeraiah S, Mehra N. COVID-19 Vaccine Uptake in Patients with Multiple Myeloma and AL Amyloidosis: A Cross-Sectional Observational Study from India. Indian J Hematol Blood Transfus 2024; 40:30-35. [PMID: 38312195 PMCID: PMC10830937 DOI: 10.1007/s12288-023-01680-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2023] [Accepted: 07/10/2023] [Indexed: 02/06/2024] Open
Abstract
COVID-19 vaccine uptake has been comparable, if not higher, in LMICs (Low- and Middle-Income Countries) than in developed nations. Patients with plasma cell disorders are at a higher risk for developing COVID-19 related morbidity and mortality due to impaired immune responses. We report the outcome of active counselling for COVID-19 vaccines in patients with multiple myeloma (MM) and AL amyloidosis and the reasons for hesitancy in those unvaccinated. This was a cross-sectional, single-centre, observational study enrolling patients who visited the hospital between January 1, 2021 and June 30, 2021. Patients with MM and AL amyloidosis at diagnosis or follow-up were actively counselled by treating oncologists regarding the available COVID-19 vaccines (Covishield and Covaxin) during clinic visits or hospital admission. In the subsequent hospital visits, vaccination details were collected and verified. A structured interview schedule was administered to unvaccinated patients to identify the reasons behind vaccine hesitancy. Association of vaccine acceptance with socio-economic parameters and other disease parameters was studied using Chi-square test. Out of 195 patients, 178 (91%) were included in the study; 17 were lost to follow-up. At least a single dose of vaccine was administered in 86%. 79% received Covishield, whereas 21% received Covaxin. 67% received both vaccine doses. Vaccine-related side effects were mild and no vaccine-related thrombotic events were seen. Three patients died due to COVID-19-related causes, of which two were unvaccinated. The reasons for hesitancy in the 24 unvaccinated patients included: 9-poor general health conditions, 8-lack of advice from doctors, 2-fear of side effects, and 2-unavailability of vaccine delivery centres nearby. In comparison to the other studies, we report a higher vaccine uptake which can be attributed to targeted counselling by the treating oncologist and the universal free vaccination programme that is familiar to all Indians.
Collapse
Affiliation(s)
- Prabhat Ganju
- Department of Medical Oncology, Cancer Institute (WIA), Dr. S. Krishnamurthi Campus, 38 Sardar Patel Road, Chennai, Tamil Nadu 600036 India
| | - Jayachandran Perumal Kalaiyarasi
- Department of Medical Oncology, Cancer Institute (WIA), Dr. S. Krishnamurthi Campus, 38 Sardar Patel Road, Chennai, Tamil Nadu 600036 India
| | - Parathan Karunakaran
- Department of Medical Oncology, Cancer Institute (WIA), Dr. S. Krishnamurthi Campus, 38 Sardar Patel Road, Chennai, Tamil Nadu 600036 India
| | - Surendran Veeraiah
- Department of Psycho-Oncology, Cancer Institute (WIA), Dr. S. Krishnamurthi Campus, 38 Sardar Patel Road, Chennai, Tamil Nadu 600036 India
| | - Nikita Mehra
- Department of Medical Oncology, Cancer Institute (WIA), Dr. S. Krishnamurthi Campus, 38 Sardar Patel Road, Chennai, Tamil Nadu 600036 India
| |
Collapse
|
14
|
Rajkhowa P, Kalyanpur C, K R, Dsouza VS, Pattanshetty S, Narayanan P, Saravu K, Brand H. Geospatial mapping of public sentiment and infodemic on human papillomavirus vaccination in India: An indication to formulation of strategies for effective implementation. Glob Public Health 2024; 19:2348646. [PMID: 38718287 DOI: 10.1080/17441692.2024.2348646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2023] [Accepted: 04/22/2024] [Indexed: 08/21/2024]
Abstract
The implementation of Human Papillomavirus (HPV) vaccination is crucial for eliminating cervical cancer in India. The infodemic, characterised by misleading information, could hinder the successful implementation of the initiative. Misinformation related to the HPV vaccine, such as rumours, has been reported and circulated, contributing to an alarming pattern of vaccine hesitancy observed on social media. This study aimed to identify the public sentiment towards HPV vaccination based on the 'Behavioral and Social Drivers (BeSD)' framework through geospatial, content and sentiment analysis. A total of 1,487 tweets were extracted. After preprocessing, 1010 tweets were identified for sentiment and content analysis. The sentiments expressed towards the HPV vaccine are mixed, with a generally positive outlook on the vaccines. Within the population, there is a pervasive proliferation of misinformation, primarily focusing on vaccine safety and efficacy, contentious subjects, ethical considerations, and a prevalent sense of uncertainty in selecting the appropriate vaccine. These observations are crucial for developing targeted strategies to address public concerns and enhance vaccination rates. The insights gained from these results will guide policymakers, healthcare practitioners, and public health organisations to implement evidence-based interventions, thereby countering vaccine hesitancy and improving public health outcomes.
Collapse
Affiliation(s)
- Priyobrat Rajkhowa
- Department of Health Policy, Prasanna School of Public Health (PSPH), Manipal Academy of Higher Education (MAHE), Manipal, India
- Department of International Health, Care and Public Health Research Institute - CAPHRI, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
| | - Cauvery Kalyanpur
- Department of Global Health Governance, Prasanna School of Public Health, Manipal Academy of Higher Education (MAHE), Manipal, India
| | - Rakshitha K
- Department of Global Health Governance, Prasanna School of Public Health, Manipal Academy of Higher Education (MAHE), Manipal, India
| | - Viola Savy Dsouza
- Centre for Regulatory Science, Department of Health Information, Prasanna School of Public Health, Manipal Academy of Higher Education (MAHE), Manipal, India
| | - Sanjay Pattanshetty
- Department of International Health, Care and Public Health Research Institute - CAPHRI, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
- Department of Global Health Governance, Prasanna School of Public Health, Manipal Academy of Higher Education (MAHE), Manipal, India
| | - Prakash Narayanan
- Department of Health Policy, Prasanna School of Public Health (PSPH), Manipal Academy of Higher Education (MAHE), Manipal, India
| | - Kavitha Saravu
- Department of Infectious Diseases, Kasturba Medical College and Hospital, Manipal, Manipal Academy of Higher Education, Manipal, India
- Manipal Centre for Infectious Diseases, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India
| | - Helmut Brand
- Department of Health Policy, Prasanna School of Public Health (PSPH), Manipal Academy of Higher Education (MAHE), Manipal, India
- Department of International Health, Care and Public Health Research Institute - CAPHRI, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
| |
Collapse
|
15
|
Afsharinia B, Gurtoo A. Role of leadership and incentive-based programs in addressing vaccine hesitancy in India. Vaccine X 2023; 15:100346. [PMID: 37577213 PMCID: PMC10413069 DOI: 10.1016/j.jvacx.2023.100346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2022] [Revised: 07/05/2023] [Accepted: 07/06/2023] [Indexed: 08/15/2023] Open
Abstract
The current study goes beyond the popular 5Cs model of vaccine hesitancy to explore perceived social norms, role of leadership and the role of incentive-based intervention for improving the likelihood of vaccination, in a population-representative sample of adults in India (N = 1129). We investigated differences in socio-demographic status, perceived descriptive norms like vaccine behaviours, beliefs, experience and perceived injunctive norms like community and political leadership within the context of the COVID-19 pandemic are related to vaccination. Further, we examined the role of incentive-based intervention as a potentially salient predictor of adults' vaccine uptake. The study is based on a cross-sectional survey conducted in July-November 2021, which included questions about impacts of pandemic collected by phone call interview from adults' beneficiaries of Government free food schemes, across 11 states in India. The data include 81 % vaccinated and 19 % vaccine hesitant participants, with a higher proportion of business or self-employed (53.1 %) as vaccine hesitant. We performed the t-test to assess the variation between vaccinated and vaccine hesitant adults, and Exploratory Factor Analysis to uncover the underlying dimension of vaccine hesitancy. Subsequently, Binary Logistic Regression model probed the factors associated with likelihood of vaccination uptake. In contrast to the prevailing evidence, results demonstrated community and political leadership has significant negative impact on vaccination (p-value < 0.06, 95 % CI, 0.57-1.01). Incentive-based intervention offer a vital leverage to enhance positive attitude towards vaccination (p-value < 0.05, 95 % CI, 1.01-1.80). The results thus broadly highlight the limited role of political and community leaders in leveraging their influence on vaccination, the role of timely, accurate information, applications of telemedicine as an important tool to provide healthcare and the need for optimal design of incentive-based vaccination programs recommended by trusted sources.
Collapse
Affiliation(s)
- Bita Afsharinia
- Senior Research Scholar, Department of Management Studies, Indian Institute of Science, Bangalore 560012, India
| | - Anjula Gurtoo
- Senior Research Scholar, Department of Management Studies, Indian Institute of Science, Bangalore 560012, India
| |
Collapse
|
16
|
Hegde M, Raj S, Tikadar D, Nyamagoud SB. Unveiling vaccine safety: a narrative review of pharmacovigilance in India's COVID-19 vaccination. Monaldi Arch Chest Dis 2023. [PMID: 38037892 DOI: 10.4081/monaldi.2023.2793] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2023] [Accepted: 11/29/2023] [Indexed: 12/02/2023] Open
Abstract
In India, a robust vaccine pharmacovigilance system is essential to the effective implementation of COVID-19 immunization programs, ensuring the safety and efficacy of the administered vaccines. The National Expert Group on Vaccine Administration for COVID-19 and the Pharmacovigilance Programme of India have played vital roles in monitoring and analyzing adverse events following immunization (AEFI). These tools have made it easier to gather, assess, and report information about different adverse drug reactions connected to COVID-19 vaccines. However, there are several issues with India's vaccination pharmacovigilance, including underreporting and sluggish data gathering. To improve the efficiency of the pharmacovigilance system, it is crucial to address these issues and encourage active reporting by healthcare professionals and the general public. This insightful review article serves as a critical resource for shedding light on India's vaccine pharmacovigilance efforts throughout the COVID-19 vaccination drive. It also elucidates how these efforts are pivotal in bolstering public confidence in vaccines. The comprehensive coverage of reported AEFI not only showcases the commitment to vaccine safety but also helps healthcare professionals and policymakers make informed decisions to enhance the overall vaccination program.
Collapse
Affiliation(s)
- Megha Hegde
- Department of Pharmacy Practice, KLE College of Pharmacy, Hubli, Karnataka.
| | - Saurav Raj
- Department of Pharmacy Practice, KLE College of Pharmacy, Hubli, Karnataka.
| | - Dhananjay Tikadar
- Department of Pharmacy Practice, KLE College of Pharmacy, Hubli, Karnataka.
| | | |
Collapse
|
17
|
Trivedi K, Anand S, Atta P, Kujur M, Kujur A, Singh S, Prasad A, Kiran KA. Drivers for COVID 19 vaccine hesitancy among breastfeeding women in Eastern tribal state, India. J Family Med Prim Care 2023; 12:3167-3171. [PMID: 38361909 PMCID: PMC10866274 DOI: 10.4103/jfmpc.jfmpc_821_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2023] [Revised: 06/29/2023] [Accepted: 07/04/2023] [Indexed: 02/17/2024] Open
Abstract
Background In the COVID-19 pandemic age, vaccination hesitancy also known as vaccine refusal is a cause for worry since it hinges on the five Cs of confidence, complacency, convenience, calculation, and shared responsibility. The current study was to pinpoint the elements that contribute to breastfeeding women's hesitation to receive the coronavirus disease-19 (COVID-19) vaccine. Materials and Methods A cross-sectional observational study was carried out at the Department of Obstetrics and Gynaecology, Tertiary Care Hospital, Ranchi, Jharkhand. Result Out of 365 nursing mothers, 242 (66.3%) were hesitant to get the COVID-19 vaccination. Those who chose not to receive the COVID-19 vaccination mostly belong to those aged 18 to 25 (38.1%), living in rural regions (44.9%), and belonging to non-tribal ethnic groups (41.1%). On application of logistic regression, it was found that rural areas had 3 times higher rate of vaccine hesitancy than urban residents, and that husbands' education levels up to the 12th grade had a 3.55 times higher rate and 5 times agriculture by husband's occupation, which was statistically significant (P value less than 0.05) The most prevalent grounds for rejection were fear of side effects (85.8%) and worry of adverse effects on newborns (83.48%). Conclusion Both husband and wife, who had completed high school and were aware of the vaccination, were fearful of the COVID-19 vaccine. Concerns about the side effects and undesirable effects of vaccination on their newborns were the main reasons for refusal.
Collapse
Affiliation(s)
- Kiran Trivedi
- Department of Obstetrics and Gynaecology, Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand, India
| | - Shikha Anand
- Department of Obstetrics and Gynaecology, Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand, India
| | - Prami Atta
- Department of Obstetrics and Gynaecology, Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand, India
| | - Manisha Kujur
- Department of Community Medicine, Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand, India
| | - Anit Kujur
- Department of Community Medicine, Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand, India
| | - Shashibala Singh
- Department of Obstetrics and Gynaecology, Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand, India
| | - Anupa Prasad
- Department of Biochemistry, Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand, India
| | - Kumari Asha Kiran
- Department of Community Medicine, Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand, India
| |
Collapse
|
18
|
Kumar P, Chakraborty AB, Dhandore S, Dhalaria P, Singh AK, Agarwal D, Singh K, Priyadarshini P, Jain P, Bahl V, Taneja G. Balancing Routine and Pandemic: The Synergy of India's Universal Immunization Program and COVID-19 Vaccination Program. Vaccines (Basel) 2023; 11:1776. [PMID: 38140180 PMCID: PMC10747509 DOI: 10.3390/vaccines11121776] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2023] [Revised: 11/24/2023] [Accepted: 11/26/2023] [Indexed: 12/24/2023] Open
Abstract
The COVID-19 pandemic posed substantial challenges to healthcare systems globally and severely disrupted essential health services, including routine immunization programs. In India, these disruptions were exacerbated due to the sudden emergence of the pandemic and lockdown measures, leading to mass migrations and a shortage of healthcare workers. Caregivers' concerns about routine immunization sessions further compounded the problem, resulting in a sharp increase in zero-dose children. This review paper examines India's strategies for conducting one of the world's largest COVID-19 vaccination programs while effectively restoring and perpetuating its Universal Immunization Program (UIP). The UIP played a pivotal role in sustaining immunization services during the pandemic, ultimately improving immunization coverage compared to pre-pandemic levels. India's accomplishments in this regard are highlighted through key performance indicators, the reach of immunization services, a reduction in zero-dose children, and antigen-wise coverage. The paper also discusses the successful integration of COVID-19 vaccination within the UIP framework, underscoring the significance of existing infrastructure, technology, and capacity building. India's dedication to concurrently managing routine immunization and COVID-19 vaccination showcases the adaptability and resilience of its healthcare system. India's journey serves as a global example of efficient mass immunization during challenging times, emphasizing the importance of political will, healthcare infrastructure investment, skilled healthcare workforces, and comprehensive vaccination programs. In a world grappling with the dual challenge of COVID-19 and routine immunization, India's experience provides a roadmap for strengthening healthcare systems and promoting public health as the critical agenda in challenging times.
Collapse
Affiliation(s)
- Pawan Kumar
- Immunization Division, Ministry of Health & Family Welfare, New Delhi 110011, India
| | | | - Suhas Dhandore
- Immunization Division, Ministry of Health & Family Welfare, New Delhi 110011, India
| | - Pritu Dhalaria
- Immunization Technical Support Unit, Ministry of Health & Family Welfare, New Delhi 110070, India
| | - Ajeet Kumar Singh
- Immunization Technical Support Unit, Ministry of Health & Family Welfare, New Delhi 110070, India
| | - Disha Agarwal
- Immunization Technical Support Unit, Ministry of Health & Family Welfare, New Delhi 110070, India
| | - Kapil Singh
- Immunization Division, Ministry of Health & Family Welfare, New Delhi 110011, India
| | - Pretty Priyadarshini
- Immunization Technical Support Unit, Ministry of Health & Family Welfare, New Delhi 110070, India
| | - Paras Jain
- Immunization Technical Support Unit, Ministry of Health & Family Welfare, New Delhi 110070, India
| | - Vidushi Bahl
- Immunization Technical Support Unit, Ministry of Health & Family Welfare, New Delhi 110070, India
| | - Gunjan Taneja
- Bill & Melinda Gates Foundation, New Delhi 110067, India
| |
Collapse
|
19
|
Dinesh RJ, Dhanalakshmi R, Jency PJ, Srividya A, Vijayakumar B, Kumar A. Factors for hesitancy towards vaccination against COVID-19 among the adult population in Puducherry, India - a cross sectional study. BMC Public Health 2023; 23:2217. [PMID: 37950181 PMCID: PMC10636884 DOI: 10.1186/s12889-023-17095-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2023] [Accepted: 10/29/2023] [Indexed: 11/12/2023] Open
Abstract
BACKGROUND Vaccine hesitancy is a complex phenomenon that threatens global health. Present-day communication technology has paved the way for self-education but also contributed to the infodemic surrounding vaccination. This has resulted in pockets of people who are reluctant, refuse recommended vaccinations, or choose to delay being vaccinated. The present study was designed to estimate the magnitude of hesitancy towards the COVID-19 vaccination and determine its associated factors in the community. METHODS This cross-sectional study was conducted among 776 adults aged ≥ 18 years in 15 clusters in Puducherry district, India, between March 2022 and May 2022. Face-to-face interviews were conducted using a validated, structured questionnaire. Socio-demographic variables, co-morbidities, attitudes towards vaccination, etc., were expressed as frequencies and percentages. Vaccine hesitancy was dichotomized with the median score as the cut-off and reported as a proportion with a 95% confidence interval. Univariate and multivariate analyses were carried out to determine the factors associated with vaccine hesitancy. RESULTS The mean age of participants was 43.3 ± 14.8 years, with the majority being female (67.0%). Nearly 92.4%, 74.4%, and 0.5% of participants received their first, second, and precautionary doses, respectively, during the study period. Among the unvaccinated, 93.2% were unwilling to receive any dose of vaccination. More than half of the participants were hesitant towards vaccination, according to the vaccine hesitancy scale. Participants aged above 45 years were less hesitant, while those educated up to school level, belonging to the upper socio-economic class, never tested for COVID-19 in the past, and having a negative attitude towards vaccination were significantly associated with higher vaccine hesitancy. CONCLUSIONS It is imperative to address vaccine hesitancy by alleviating existing fears and misconceptions in the community through efficient communication strategies to win the fight against current as well as future public health emergencies.
Collapse
Affiliation(s)
- Raja Jeyapal Dinesh
- Unit of Epidemiology & Operational Research, ICMR-VCRC, Indira Nagar, Puducherry, 605 006, India.
| | - Rajendran Dhanalakshmi
- Unit of Epidemiology & Operational Research, ICMR-VCRC, Indira Nagar, Puducherry, 605 006, India
| | - Priskilla Johnson Jency
- Unit of Epidemiology & Operational Research, ICMR-VCRC, Indira Nagar, Puducherry, 605 006, India
| | | | | | | |
Collapse
|
20
|
Faraz A, Hina M, Atif A, Sumbul D, Mahmood SE, Riaz F, Khan MS, Ahmad A, Ahmad MT, Parvez A, Zeyaullah M. Knowledge, acceptance, motivators and barriers of booster dose of COVID-19 vaccination among dental patients: A cross-sectional study. Medicine (Baltimore) 2023; 102:e35747. [PMID: 37960831 PMCID: PMC10637537 DOI: 10.1097/md.0000000000035747] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/18/2023] [Accepted: 09/29/2023] [Indexed: 11/15/2023] Open
Abstract
Given the lingering threat of COVID infection, questions are being raised if coronavirus disease 2019 (COVID-19) vaccine needs annual or regular boosters to maintain high levels of immunity against both the original virus and variants. This study was designed to evaluate the knowledge, acceptance, motivators and barriers of the booster dose of COVID-19 vaccine among the dental patients of District Lucknow, India. A total of 297 respondents were selected by a convenience sampling method in this cross-sectional study from various dental clinics. An anonymous, self-administered, closed-ended questionnaire was used. Overall 37.7% respondents reported to have taken all 3 doses and 57.9% had taken single/double doses. Correct information about booster doses shows a significant association with the number of doses taken. The majority had information about the availability of the Pfizer booster vaccine (69.0%). About 58% of participants had information about the technology used in booster doses. The hesitancy for booster doses and the development of natural immunity by infection show significant associations with the number of doses taken. Only 18.2% patients had hesitation about the booster dose and most of them 78.8% recommended others to take the booster vaccine as soon as possible. The majority assumed that previous COVID-19 vaccines can help them get immune (21.5%) followed by not much research has been done on the booster vaccines (15.5%) and their chronic diseases warn them against the booster dose administration (12.5%). Nearly 18.2% of respondents had hesitation about booster dose and less than one third of the respondents trusted a government source for information about booster dose of COVID vaccine. Nearly 36 % did not know that the booster dose of COVID vaccine is available at health centers. Dental health professionals and policymakers should implement and support strategies to ensure people are vaccinated for COVID-19 booster doses.
Collapse
Affiliation(s)
- Ali Faraz
- Department of Prosthodontics and Crown & Bridge, Career Post Graduate Institute of Dental Sciences and Hospital, Lucknow UP, India
| | - Malik Hina
- Department of Prosthodontics and Crown & Bridge, Career Post Graduate Institute of Dental Sciences and Hospital, Lucknow UP, India
| | - Ali Atif
- Department of Oral and Maxillofacial Surgery, Saraswati Dental College, Lucknow, UP, India
| | - Dr Sumbul
- Department of Anatomy, King George Medical University, Lucknow, UP, India
| | - Syed E Mahmood
- Department of Family and Community Medicine, College of Medicine, King Khalid University, Abha, Saudi Arabia
| | - Fatima Riaz
- Department of Family and Community Medicine, College of Medicine, King Khalid University, Abha, Saudi Arabia
| | - Mohammad Suhail Khan
- Department of Public Health, College of Applied Medical Sciences, Khamis Mushait, King Khalid University, Abha, Saudi Arabia
| | - Ausaf Ahmad
- Department of Community Medicine, Integral University, Lucknow, India
| | - Mohammad Tauheed Ahmad
- Department of Medical Education, College of Medicine, King Khalid University, Abha, Saudi Arabia
| | - Ashib Parvez
- Department of Community Medicine F.H. Medical College, Etmadpur, Agra, UP, India
| | - Md Zeyaullah
- Department of Basic Medical Science, College of Applied Medical Sciences, Khamis Mushayt Campus, King Khalid University (KKU), Abha, Saudi Arabia
| |
Collapse
|
21
|
Mendu SB, Singavarapu PR, Kota V, Sheri AR, Kotha R. Generalised Tonic-Clonic Seizure in Adolescents Following COVID-19 Vaccination: A Case Report on a Mere Co-incidence. Cureus 2023; 15:e40992. [PMID: 37503470 PMCID: PMC10371194 DOI: 10.7759/cureus.40992] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/26/2023] [Indexed: 07/29/2023] Open
Abstract
Coronavirus disease 2019 (COVID-19) is a novel infectious disease caused by the severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2). This disease caused one of the largest pandemics in human history. During the second COVID-19 surge, the Indian government faced the threat posed by the growing COVID-19 pandemic by informing citizens and encouraging the use of preventive measures such as face masks, hand sanitization, personal protective equipment, quarantines, and vaccination. Vaccination is an effective prophylactic intervention in public health, and COVID-19 vaccines have been developed to achieve immunity against viruses and stop the transmission of infection. However, vaccines have side effects, and by early 2021, many doubts arose regarding COVID-19 vaccinations. Few people were not taking immunization because post-immunization adverse events were reported. We are reporting a case of seizures after immunization with Covaxin.
Collapse
Affiliation(s)
| | | | - Venu Kota
- Pediatrics, Government Medical College Siddipet, Siddipet, IND
| | | | - Rakesh Kotha
- Neonatology, Osmania Medical College, Hyderabad, IND
| |
Collapse
|
22
|
Agarwal SK, Naha M. COVID-19 Vaccine Coverage in India: A District-Level Analysis. Vaccines (Basel) 2023; 11:948. [PMID: 37243052 PMCID: PMC10221184 DOI: 10.3390/vaccines11050948] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2023] [Revised: 04/15/2023] [Accepted: 04/26/2023] [Indexed: 05/28/2023] Open
Abstract
India implemented the largest COVID-19 vaccination drive in the world, through which it vaccinated the majority of its population. Lessons from the Indian COVID-19 vaccination experience can be invaluable for other LMICs as well as for preparedness for future outbreaks. Our study is designed to explore the factors associated with COVID-19 vaccination coverage in India at the district level. We used data from COVID-19 vaccination in India combined with several other administrative data to create a unique data set that facilitated a spatio-temporal exploratory analysis by uncovering the factors associated with vaccination rates across different vaccination phases and districts. We found evidence that past reported infection rates were positively correlated with COVID-19 vaccination outcomes. Past cumulative COVID-19 deaths as a proportion of district populations were associated with lower COVID-19 vaccination, but the percentage of past reported infection was positively correlated with first-dose COVID-19 vaccination, which might indicate a positive role of higher awareness created by a higher reported infection rate. Districts that on average had a higher population burden per health centre were likely to have lower COVID-19 vaccination rates. Vaccination rates were lower in rural areas relative to urban areas, whereas the association with literacy rate was positive. Districts with a higher percentage of children with complete immunisation were associated with higher COVID-19 vaccination, whereas low vaccination was observed in districts that had higher percentages of wasted children. COVID-19 vaccination was lower among pregnant and lactating women. Higher vaccination was observed among populations with higher blood pressure and hypertension (which were a few of the co-morbidities associated with COVID-19 infection).
Collapse
Affiliation(s)
- Sandip K. Agarwal
- Indian Institute of Science Education and Research (IISER), Bhopal 462066, India
| | | |
Collapse
|
23
|
Kumari M, Mondal H, Marndi G, Juhi A. Evaluation of the Effectiveness of a Structured Educational Program on Improving the Knowledge of COVID-19 Among the Vaccine-Reluctant Population in a Block of Jharkhand, India. Cureus 2023; 15:e38628. [PMID: 37284394 PMCID: PMC10241108 DOI: 10.7759/cureus.38628] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/05/2023] [Indexed: 06/08/2023] Open
Abstract
Background Low vaccination uptake is a major public health concern and is more prevalent in rural areas. Educational interventions have been proposed as an effective strategy to increase vaccine acceptance. The objective of this study was to assess the impact of an educational program on acquiring knowledge for promoting vaccination uptake among a sample of participants. Methodology This study was conducted in a rural area in the state of Jharkhand, India. The study period was from July 2022 to September 2022. The area was surveyed for COVID-19 vaccination and a total of 510 people did not take any dose or took only the first dose and then skipped the second dose. An educational program was designed in the local language. The knowledge of the sample was assessed before and after a week of intervention with a surveyor-administered questionnaire. The vaccination status before and after the intervention was also recorded. We used the chi-square test, Fisher's exact test, and binomial test for comparing the categorical variables. Results A total of 178 participants' data were analyzed. The majority of the participants were in the age group of 18-25 years. The pre-intervention score regarding the knowledge of COVID-19 and vaccination was 18.93 ± 5.10 which significantly increased after the intervention to 25.06 ± 4.35 (p <0.0001). The number of individuals receiving vaccination significantly increased. Before the program, 95 participants did not take the vaccine and 83 received the first dose and did not take the second dose. After the program, 17 participants did not take the vaccine, 161 completed the first dose, and 112 completed the second dose (p <0.0001). Conclusions The educational program was successful in improving knowledge and awareness about vaccination, leading to an increase in the number of individuals receiving vaccination. These findings suggest the importance of educational interventions in the local language in promoting vaccination uptake and can be used to design effective public health campaigns to increase vaccine acceptance.
Collapse
Affiliation(s)
- Muskan Kumari
- Physiology, All India Institute of Medical Sciences, Deoghar, Deoghar, IND
| | - Himel Mondal
- Physiology, All India Institute of Medical Sciences, Deoghar, Deoghar, IND
| | - Gujaram Marndi
- Pharmacology, Dharanidhar Medical College and Hospital, Keonjhar, Kendujhar, IND
| | - Ayesha Juhi
- Physiology, All India Institute of Medical Sciences, Deoghar, Deoghar, IND
| |
Collapse
|
24
|
Soni GK, Bhatnagar A, Gupta A, Kumari A, Arora S, Seth S, Rastogi A, Kanagat N, Fields R. Engaging Faith-Based Organizations for Promoting the Uptake of COVID-19 Vaccine in India: A Case Study of a Multi-Faith Society. Vaccines (Basel) 2023; 11:vaccines11040837. [PMID: 37112749 PMCID: PMC10140837 DOI: 10.3390/vaccines11040837] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2023] [Revised: 03/27/2023] [Accepted: 03/29/2023] [Indexed: 04/29/2023] Open
Abstract
Mass vaccination, currently the most promising solution to contain communicable diseases, including COVID-19 requires collaboration between a variety of partners to improve the supply and demand and alleviate vaccine inequity. Vaccine hesitancy features in WHO's list of top 10 threats to global health, and there is plethora of disinformation instigating conflict between COVID-19 vaccination drive and religious sentiments. Negotiating public health partnerships with FBOs (Faith Based Organizations) has always been challenging. A handful of faith leaders have always shown resistance to ideas such as child immunization, and family planning. Many others have been supportive on other fronts like helping people with food, shelter, and medical aid in the times of public health crisis. Religion is an important part of life for the majority of the Indian population. People confide in faith-based leaders in the times of difficulty. This article presents experiences from the strategic engagement with FBOs (entities dedicated to specific religious identities, often including a social or moral component) to promote uptake of COVID-19 vaccination, especially among the vulnerable and marginalized communities. The project team collaborated with 18 FBOs and more than 400 religious institutions to promote COVID-19 vaccination and build confidence for the vaccination program. As a result, a sustainable network of sensitized FBOs from diverse faiths was created. The FBOs mobilized and facilitated vaccination of 0.41 million beneficiaries under the project.
Collapse
Affiliation(s)
- Gopal Krishna Soni
- John Snow India Pvt. Ltd. (JSIPL)-Plot No. 5 & 6, First Floor Allied House, Pocket 10, Sector B, Vasant Kunj, Delhi 110070, India
| | - Anumegha Bhatnagar
- John Snow India Pvt. Ltd. (JSIPL)-Plot No. 5 & 6, First Floor Allied House, Pocket 10, Sector B, Vasant Kunj, Delhi 110070, India
| | - Anil Gupta
- John Snow India Pvt. Ltd. (JSIPL)-Plot No. 5 & 6, First Floor Allied House, Pocket 10, Sector B, Vasant Kunj, Delhi 110070, India
| | - Amrita Kumari
- John Snow India Pvt. Ltd. (JSIPL)-Plot No. 5 & 6, First Floor Allied House, Pocket 10, Sector B, Vasant Kunj, Delhi 110070, India
| | - Sonal Arora
- John Snow India Pvt. Ltd. (JSIPL)-Plot No. 5 & 6, First Floor Allied House, Pocket 10, Sector B, Vasant Kunj, Delhi 110070, India
| | - Surbhi Seth
- John Snow India Pvt. Ltd. (JSIPL)-Plot No. 5 & 6, First Floor Allied House, Pocket 10, Sector B, Vasant Kunj, Delhi 110070, India
| | - Apurva Rastogi
- John Snow India Pvt. Ltd. (JSIPL)-Plot No. 5 & 6, First Floor Allied House, Pocket 10, Sector B, Vasant Kunj, Delhi 110070, India
| | - Natasha Kanagat
- John Snow Inc., 2733 Crystal Drive, 4th Floor, Arlington, VA 22202, USA
| | - Rebecca Fields
- John Snow Inc., 2733 Crystal Drive, 4th Floor, Arlington, VA 22202, USA
| |
Collapse
|
25
|
Choudhary R, Choudhary RR, Pervez A. COVID-19 Vaccination and Gaps in India. Cureus 2023; 15:e37490. [PMID: 37187643 PMCID: PMC10179641 DOI: 10.7759/cureus.37490] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2023] [Accepted: 04/08/2023] [Indexed: 05/17/2023] Open
Abstract
INTRODUCTION The important variables that influence how many people are vaccinated against coronavirus disease (COVID-19) in India include vaccine skepticism, socioeconomic status, and multi-dimensional deprivation. Our preliminary research suggests that uncertainty about the safety of the COVID-19 vaccine has a large and detrimental effect on immunization rates. MATERIALS AND METHODS The Crucial Subsets Survey (CSS) is performed daily on Facebook to recruit participants for cross-section surveys by academic institutions, the Delphi Research Center, and the University of Maryland's Joint Program in Survey Methodology. Facebook will notify a portion of its daily users to take a vote. CSS adds behavior, attitude toward policy and preventive measures, economic consequences, and critical indicators to official reporting data. RESULTS It has been estimated that a 30% drop in vaccination coverage may be attributed to a 1% rise in vaccine skepticism. Similarly, higher rates of multidimensional poverty are associated with lower rates of COVID-19 vaccine coverage. When the multidimensional poverty index (MPI), or the percentage of persons living in extreme poverty, rises by one unit, immunization rates fall by around half. It suggests that higher rates of socioeconomic hardship have unfavorable effects on health outcomes like vaccination rates. We also showed that gender is a major factor in influencing how internet availability affects vaccination rates and hesitation. We discovered that male vaccination rates went up in tandem with male internet use. This might be because of the digital divide and India's reliance on digital technologies like the COVID Vaccine Intelligence Network (COWIN), AAROGYA SETU, and Imphal, India, to assign and register for COVID-19 vaccinations, while males have greater digital excess than females. While male internet access is significantly and positively correlated with coverage, female internet access is significantly and negatively correlated with coverage. Women are less likely to seek medical care and have more vaccination reluctance than men, both of which contribute to this trend. CONCLUSION The government's strategy for disseminating information about the COVID-19 vaccination should prioritize reaching out to women. In order to recruit more women to vaccination clinics, it is important to raise public awareness about the need for immunization among women via the media and community outreach.
Collapse
Affiliation(s)
- Rajkamal Choudhary
- Department of Medicine, Jawaharlal Nehru Medical College, Bhagalpur, IND
| | - Raj Rani Choudhary
- Department of Obstetrics and Gynaecology, Nalanda Medical College, Patna, IND
| | - Anjum Pervez
- Department of Dialysis, Jawahar Lal Nehru Medical College, Bhagalpur, IND
| |
Collapse
|
26
|
Ayyalasomayajula S, Dhawan A, Karattuthodi MS, Thorakkattil SA, Abdulsalim S, Elnaem MH, Sridhar S, Unnikrishnan MK. A Systematic Review on Sociodemographic, Financial and Psychological Factors Associated with COVID-19 Vaccine Booster Hesitancy among Adult Population. Vaccines (Basel) 2023; 11:vaccines11030623. [PMID: 36992207 DOI: 10.3390/vaccines11030623] [Citation(s) in RCA: 11] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Revised: 03/02/2023] [Accepted: 03/03/2023] [Indexed: 03/12/2023] Open
Abstract
Background: While considerable evidence supports the safety and efficacy of COVID-19 vaccines, a sizable population expresses vaccine hesitancy. As per the World Health Organization, vaccine hesitancy is one of the top 10 hazards to global health. Vaccine hesitancy varies across countries, with India reporting the least vaccine hesitancy. Vaccine hesitancy was higher toward COVID-19 booster doses than previous shots. Therefore, identifying factors determining COVID-19 vaccine booster hesitance (VBH) is the sine qua non of a successful vaccination campaign. Methodology: This systematic review followed Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) 2020 standards. A total of 982 articles were pooled from Scopus, PubMed and Embase, while 42 articles that addressed the factors of COVID-19 VBH were finally included for further analysis. Result: We identified factors responsible for VBH and divided them into three major groups: sociodemographic, financial, and psychological. Hence, 17 articles stated age to be a major factor for vaccine hesitancy, with most reports suggesting a negative correlation between age and fear of poor vaccination outcomes. Nine studies found females expressing greater vaccine hesitancy than males. Trust deficit in science (n = 14), concerns about safety and efficacy (n = 12), lower levels of fear regarding infection (n = 11), and worry about side effects (n = 8) were also reasons for vaccine hesitancy. Blacks, Democrats, and pregnant women showed high vaccine hesitancy. Few studies have stated income, obesity, social media, and the population living with vulnerable members as factors influencing vaccine hesitancy. A study in India showed that 44.1% of vaccine hesitancy towards booster doses could be attributed dominantly to low income, rural origin, previously unvaccinated status, or living with vulnerable individuals. However, two other Indian studies reported a lack of availability of vaccination slots, a lack of trust in the government, and concerns regarding safety as factors for vaccine hesitancy toward booster doses. Conclusion: Many studies have confirmed the multifactorial nature of VBH, which necessitates multifaceted, individually tailored interventions that address all potentially modifiable factors. This systematic review chiefly recommends strategizing the campaign for booster doses by identifying and evaluating the reasons for vaccine hesitancy, followed by appropriate communication (at both individual and community levels) about the benefits of booster doses and the risk of losing immunity without them.
Collapse
Affiliation(s)
- Shruti Ayyalasomayajula
- Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Madhav Nagar 576104, India
| | - Aditi Dhawan
- Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Madhav Nagar 576104, India
| | - Mohammed Salim Karattuthodi
- Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Madhav Nagar 576104, India
| | | | - Suhaj Abdulsalim
- Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, Buraydah 52571, Saudi Arabia
| | - Mohamed Hassan Elnaem
- School of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town 11800, Malaysia
| | - Sathvik Sridhar
- Department of Clinical Pharmacy & Pharmacology, RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates
| | | |
Collapse
|
27
|
Chavda VP, Balar P, Vaghela D, Solanki HK, Vaishnav A, Hala V, Vora L. Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management. Vaccines (Basel) 2023; 11:160. [PMID: 36680006 PMCID: PMC9860853 DOI: 10.3390/vaccines11010160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2022] [Revised: 12/31/2022] [Accepted: 01/04/2023] [Indexed: 01/15/2023] Open
Abstract
Omicron variants have highly influenced the entire globe. It has a high rate of transmissibility, which makes its management tedious. There are various subtypes of omicron, namely BA.1, BA.2, BA.3, BA.4, and BA.5. Currently, one omicron subvariant BF.7 is also immersed in some parts of India. Further studies are required for a better understanding of the new immersing SARS-CoV-2 subvariant of the omicron. They differ in the mutation of the spike proteins, which alters their attachment to the host receptor and hence modifies their virulence and adaptability. Delta variants have a great disastrous influence on the entire world, especially in India. While overcoming it, another mutant catches the pace. The Indian population is highly affected by omicron variants. It alters the entire management and diagnosis system against COVID-19. It demanded forcemeat in the health care system, both qualitatively and quantitively, to cope with the omicron wave. The alteration in spike protein, which is the major target of vaccines, leads to varied immunization against the subvariants. The efficacy of vaccines against the new variant was questioned. Every vaccine had a different shielding effect on the new variant. The hesitancy of vaccination was a prevalent factor in India that might have contributed to its outbreak. The prevalence of omicron, monkeypox, and tomato flu shared some similarities and distinct features when compared to their influence on the Indian population. This review emphasizes the changes omicron brings with it and how the Indian health care system outrage this dangerous variant.
Collapse
Affiliation(s)
- Vivek P. Chavda
- Department of Pharmaceutical Chemistry, L. M. College of Pharmacy, Ahmedabad 380009, Gujarat, India
| | - Pankti Balar
- Pharmacy Section, L. M. College of Pharmacy, Ahmedabad 380009, Gujarat, India
| | - Dixa Vaghela
- Pharmacy Section, L. M. College of Pharmacy, Ahmedabad 380009, Gujarat, India
| | - Hetvi K. Solanki
- Pharmacy Section, L. M. College of Pharmacy, Ahmedabad 380009, Gujarat, India
| | - Akta Vaishnav
- Pharmacy Section, L. M. College of Pharmacy, Ahmedabad 380009, Gujarat, India
| | - Vivek Hala
- Pharmacy Section, L. M. College of Pharmacy, Ahmedabad 380009, Gujarat, India
| | - Lalitkumar Vora
- School of Pharmacy, Queen’s University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK
| |
Collapse
|
28
|
Napolitano F, Miraglia del Giudice G, Angelillo S, Fattore I, Licata F, Pelullo CP, Di Giuseppe G. Hesitancy towards Childhood Vaccinations among Parents of Children with Underlying Chronic Medical Conditions in Italy. Vaccines (Basel) 2022; 10:vaccines10081254. [PMID: 36016141 PMCID: PMC9416633 DOI: 10.3390/vaccines10081254] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2022] [Revised: 08/01/2022] [Accepted: 08/01/2022] [Indexed: 02/04/2023] Open
Abstract
Background: This study was designed to evaluate vaccination hesitancy and behaviors among parents of children with chronic conditions. Methods: This cross-sectional study was conducted from June to December 2021 in three public hospitals in southern Italy. Data were collected using a face-to-face interview of parents of children up to 17 years of age with at least one chronic condition. Results: Of the 532 parents approached, 444 agreed to participate, with a response rate of 83.4%. Almost half of parents (43%) knew that children with chronic diseases are at greater risk of complications from VPDs, and 21.6% knew all the vaccinations available in Italy. Additionally, 55.9% felt that vaccine-preventable diseases (VPDs) are very dangerous for their children, and 28.7% were very worried about the side effects of vaccines. The result of the Parent Attitudes about Childhood Vaccine (PACV) score indicated that 23.2% of parents were hesitant about vaccinations. Parental vaccine hesitancy was significantly more common among parents who had female children, among those who did not know the recommended vaccinations, among those who had a higher concern of potential side effects of the vaccines, among those who believed that the administration of the vaccinations was not useful, and among who received information on recommended vaccination from the internet, social and mass media. Conclusions: Important efforts by policy makers and healthcare providers must be implemented to counter vaccine hesitancy among parents.
Collapse
Affiliation(s)
- Francesco Napolitano
- Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
| | | | - Silvia Angelillo
- Department of Health Sciences, University of Catanzaro ‘‘Magna Græcia”, 88100 Catanzaro, Italy
| | - Italo Fattore
- Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
| | - Francesca Licata
- Department of Health Sciences, University of Catanzaro ‘‘Magna Græcia”, 88100 Catanzaro, Italy
| | - Concetta Paola Pelullo
- Department of Movement Sciences and Wellbeing, University of Naples “Parthenope”, 80133 Naples, Italy
| | - Gabriella Di Giuseppe
- Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
- Correspondence: ; Tel.: +39-081-5667708
| |
Collapse
|
29
|
Prakash A, Aggarwal R. Is the fight against COVID-19 falling prey to vaccine hesitancy? INDIAN JOURNAL OF MEDICAL SPECIALITIES 2022. [DOI: 10.4103/injms.injms_131_22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|